None listed
Conditions
Interventions
Intervention1: Test Regime
(Serum + Men s Hair Growth Supplement + DHT Blocker Supplement)
: ThriveCo Hair Serum 2.0: Approx. 0.5 ml (half dropper) hair serum will be applied to scalp area of hair lo
Sponsors
Anveya Living Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult male participants between the ages of 40 to 60 years (both inclusive) at the time of consent. 2. Participants with Norwood Pattern II to IV of hair loss. 3. Participants who are experiencing hair thinning or excessive shedding for at least 3 6 months. 4. Participants with minimum hair length of 2 inches. 5. Participants having good general health as determined by the Investigator on the basis of medical history and vital signs.
Exclusion criteria
Exclusion criteria: 1. Participants with clinical diagnosis of hair loss disorder such as alopecia areata, or scarring forms of alopecia or advanced pattern hair loss. 2. Participants with scalp hair loss at the treatment area, due to disease, injury, or medical therapy. 3. Participants with history of any dermatological condition (like psoriasis or infections) of the scalp other than hair loss OR with any active scalp disease which may interfere in the study. 4. Participants with any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedures. 5. Participants with a history of chronic health conditions (eg, diabetes, hypertension, chronic renal failure, heart and liver disease), endocrine abnormalities including stable thyroid disease, psychiatric illness, bariatric surgery/eating disorders such as bulimia or binge eating, cardiovascular surgery, or history of any other major surgery. 6. Participants with the history of malignancy OR known history of autoimmune thyroid disease, any other thyroid disorder/abnormality or other autoimmune disorders. 7. Participants with known allergy or sensitivity to cosmetic products and/or any ingredients of the test product. 8. Participants who had undergone chemotherapy or radiation within the last 2 years. 9. Participants who have undergone hair regrowth treatments (minoxidil, finasteride, PRP, etc.) within 6 months before screening. 10. Participants using anti-androgenic therapies or using low-level lasers for hair growth within 3 months. 11. Participants who have applied topical treatment for hair loss for at least 4 weeks and any systemic treatment for at least 3 months, prior to their participation in the study. 12. Participants with a history or presence of significant alcoholism or drug abuse and smoking or consumption of tobacco products. 13. Any other condition which could warrant exclusion from the study, as per the investigator s discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Instrumental assessment of Hair thickness and Hair growth rateTimepoint: Day 00, Day 45 and Day 90 | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical assessment of anagen and telogen ratio (A:T ratio), hair fall, hair strength, hair and scalp related parametersTimepoint: Day 00, Day 45 and Day 90;Instrumental assessment of hair density.Timepoint: Day 00, Day 45 and Day 90;Laboratory assessments of hormonal and nutritional blood markersTimepoint: Day 00 and Day 90;Participant Evaluation QuestionnaireTimepoint: Day 45 and Day 90 | — |
Countries
India
Contacts
Public ContactMr Saurav Patnaik
Cliantha Research
Outcome results
None listed